Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Darunavir vs Atazanavir in HIV
NCT00757783Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Johnson & Johnson. Started Oct 2008; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00757783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00757783.